Two ancient variola virus genomes recovered from mummified remains in northern Chile have been published in Science Advances (reported 2026-07-30), and they raise a question the paper itself does not fully answer: what does it mean to generate new sequence data on a select agent when no living virus is anywhere near the sample?
What was recovered
The two genomes come from mummified Indigenous individuals of the Inca/early-colonial era, radiocarbon- and context-dated to roughly 1492-1631 CE, from northern Chile. The study is led by Bruno Romero Gonzalez and Shigeki Nakagome at Trinity College Dublin, with Constanza de la Fuente Castro at the Universidad de Chile and Ana Duggan at the Public Health Agency of Canada’s National Microbiology Laboratory as co-authors. Researchers identified the viral fragments by screening the mummies’ sequencing data with software built to detect the genetic signatures of ancient bacteria and viruses, rather than by targeted search for a known pathogen.
Phylogenetically, the recovered lineage sits between early-medieval European variola strains and the lineages that gave rise to more recent smallpox, according to the researchers’ analysis as reported by the study authors and covered in the Eureka Alert institutional release. The genomes also show the reductive evolution pattern already documented in other historic variola genomes: mutations disabling genes that had become unnecessary as the virus specialized to a single human host, consistent with a virus narrowing its host range over time. The published account does not give a precise date range for when specific genes were lost, only that the pattern is consistent with adaptation across the colonial period; that finer chronology should be treated as unresolved until the primary paper’s supplementary data is checked directly.
The specialist angle: sequence data on a select agent, without a live virus
Variola virus is one of the most tightly restricted pathogens in the world. Following the WHO-monitored destruction of remaining stocks outside two authorized high-containment repositories, live virus itself is not something an ancient-DNA lab works with. What this study generated instead is fragmentary, degraded, post-mortem sequence data recovered from archaeological remains — genetic information about variola’s history and diversity that did not pass through either of the two WHO-recognized live-virus repositories, and did not require handling live virus to produce.
That distinction matters for how research-security and biosecurity policy frameworks are usually written. Oversight regimes for dual-use pathogens of pandemic potential are built around control of viable organisms and the infrastructure to culture or engineer them — disclosure requirements, containment tiers, access controls on live stocks. A degraded genome pulled out of 500-year-old tissue does not fit that model, but it still expands the known genetic diversity of a select agent, in a public, peer-reviewed dataset generated entirely outside the repository framework built to govern that agent’s sequence information. Ancient-pathogen genomics is not new, but a full variola genome recovered this way is a concrete example of exactly the edge case that live-virus-centered oversight was not written to cover.
The authentication problem
Before any of this evolutionary or governance analysis is possible, researchers first have to establish that what they recovered is genuine ancient viral DNA and not modern contamination or a related, non-pathogenic orthopoxvirus picked up from the environment or the lab. Distinguishing authentic ancient pathogen DNA from contamination is a well-established, hard problem in paleogenomics generally: genuine ancient DNA tends to be short, chemically degraded, and to carry damage patterns consistent with centuries of post-mortem decay, and researchers build their case for authenticity from that pattern together with independent corroborating evidence, such as two individuals from the same context yielding closely related, near-identical viral sequences — a form of mutual internal control that is harder to explain by contamination than by genuine ancient infection. The published study does not itemize its full authentication pipeline in the coverage available at the time of writing; readers who need the exact contamination-control methodology should consult the Science Advances paper’s supplementary methods directly rather than take this summary as a substitute.
What the study does and does not claim about causation
Coverage of the paper has widely framed it as evidence that European colonization introduced smallpox to the Americas. The lead researcher’s own language is more cautious than that framing suggests. Asked about the causal link between the phylogenetic placement of the CAM9-era lineage and colonization, Romero Gonzalez is quoted as saying: “We cannot say that there is a proper causation… But it is suspicious, at the very least.” That is a phylogenetic-placement argument — where this lineage sits relative to known European and later strains — not a documented transmission-chain argument, and readers should treat the strength of the causal claim accordingly: the placement is consistent with a European-introduction narrative, it does not independently prove one.
Why this belongs on the research-governance radar now
CASRAI covered the U.S. government’s institutional controls on high-risk life-sciences research the same week this paper’s coverage circulated, and separately covered the BIOSECURE Act’s restrictions on federally funded biotech research. Neither of those policy frameworks was written with archaeological-genomics edge cases like this one in mind, and this paper is a concrete illustration of why that gap is worth closing: a peer-reviewed, publicly available dataset now exists that materially expands documented sequence diversity for a select agent, generated by a route — ancient DNA recovery from archaeological remains — that current dual-use oversight regimes, built around live-virus handling and modern biotech infrastructure, do not clearly address. Institutions running high-risk life-sciences research programs, and the compliance offices that oversee them, have a live example to work through rather than a hypothetical one.
Sources
- EurekAlert institutional release, 2026-07-30: eurekalert.org/news-releases/1137580
- Scientific American, “Chilean Mummies Reveal a Lost Lineage of Smallpox”: scientificamerican.com
This article summarizes secondary coverage of a peer-reviewed study in Science Advances verified against the EurekAlert institutional release and Scientific American’s reporting as of 2026-08-07; the underlying paper’s full methods were not independently re-verified beyond what these sources report, and specific technical claims not confirmed in either source have been omitted or generalized accordingly.
